Friedrich Schiller University Jena-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2004

  1. Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial

    Critical Care Medicine, Vol. 32, Núm. 2, pp. 332-341